New Therapeutic Options Enhance Breast Cancer Treatment: ASCO Reports
Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia
Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer
Study Finds No Link Between Pill And Breast Cancer Risk
Vasectomy Doesn’t Increase Prostate Cancer Risk
Drug Slows Tumor Growth In Metastatic Kidney Cancer
STI-571 Effects Are Lasting Against GI Stromal Tumors
Monoclonal Antibody Improves AML Response To Therapy
Protocols Approved During the Month of June 2002
Trending Stories
- Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer
- On Capitol Hill, NIH gets congressional support and RFK Jr. gets slammed
- The Directors: Ben Ho Park and Suresh Ramalingam discuss tough times, uncertainty, and resilience
“If you’re going to be an oncologist, we look at the glass 5% full, not 95% empty.” - Reflections of a cancer scientist
Maintaining the pace of novel technologies will lead to more efficient and less toxic medicines - NCI releases names of members of ad hoc working group—filling the void left by BSA
- Nobel laureate David Baltimore dies at 87
Baltimore discovered that genetic material of tumor viruses could make DNA from their RNA genome